Published in J Hyg (Lond) on October 01, 1978
Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med (1999) 3.45
Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc Natl Acad Sci U S A (1980) 3.32
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A (1989) 3.26
Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice. Antimicrob Agents Chemother (1979) 2.75
Pseudorabies virus avirulent strains fail to express a major glycoprotein. J Virol (1985) 2.70
Experimental investigation of herpes simplex virus latency. Clin Microbiol Rev (1997) 2.53
Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS. J Virol (1986) 2.41
Genetic basis of the neurovirulence of pseudorabies virus. J Virol (1984) 2.34
Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrob Agents Chemother (1980) 2.17
Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A (1990) 2.15
Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J Virol (1993) 2.01
A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture. J Virol (1989) 1.95
Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother (1998) 1.89
Proteins specified by the short unique region of the genome of pseudorabies virus play a role in the release of virions from certain cells. J Virol (1986) 1.89
Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus. J Virol (1992) 1.84
Herpes simplex virus variants restraint to high concentrations of acyclovir exist in clinical isolates. Antimicrob Agents Chemother (1982) 1.80
Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency. J Virol (1992) 1.64
De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. PLoS Pathog (2009) 1.56
Partial purification and characterization of the ribonucleotide reductase induced by herpes simplex virus infection of mammalian cells. J Virol (1981) 1.55
Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment. J Virol (1985) 1.45
Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol (2003) 1.45
Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency. J Virol (2003) 1.42
Genetic and biological analyses of a herpes simplex virus intertypic recombinant reduced specifically for neurovirulence. J Virol (1987) 1.40
The range and distribution of murine central nervous system cells infected with the gamma(1)34.5- mutant of herpes simplex virus 1. J Virol (1997) 1.39
Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity. Immunology (1981) 1.36
Resistance of peripheral autonomic neurons to in vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity. Infect Immun (1981) 1.32
Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system. J Virol (1994) 1.30
Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy. Antimicrob Agents Chemother (1982) 1.29
Mutations in accessory DNA replicating functions alter the relative mutation frequency of herpes simplex virus type 1 strains in cultured murine cells. J Virol (1994) 1.27
Genetic variability of herpes simplex virus: development of a pathogenic variant during passaging of a nonpathogenic herpes simplex virus type 1 virus strain in mouse brain. J Virol (1983) 1.27
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates. J Virol (1999) 1.26
Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus. J Virol (1989) 1.25
Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob Agents Chemother (1987) 1.24
Resistance of herpesviruses to antiviral drugs. Antimicrob Agents Chemother (1992) 1.23
Replication and virulence of pseudorabies virus mutants lacking glycoprotein gX. J Virol (1987) 1.19
Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob Agents Chemother (1985) 1.17
Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. J Virol (1986) 1.17
Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon. J Virol (1990) 1.12
Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation. J Virol (1987) 1.11
Specific inhibitors of herpes simplex virus thymidine kinase diminish reactivation of latent virus from explanted murine ganglia. Antimicrob Agents Chemother (1990) 1.08
Identification and characterization of pseudorabies virus dUTPase. J Virol (1996) 1.07
Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene. J Virol (1994) 1.06
Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity. Immunology (1981) 1.04
Localization of a herpes simplex virus neurovirulence gene dissociated from high-titer virus replication in the brain. J Virol (1988) 1.04
The African swine fever virus thymidine kinase gene is required for efficient replication in swine macrophages and for virulence in swine. J Virol (1998) 1.03
Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir. Antimicrob Agents Chemother (1987) 1.02
Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model. Antimicrob Agents Chemother (1996) 1.02
Cooperative effects between two acyclovir resistance loci in herpes simplex virus. J Virol (1984) 1.01
Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir. Antimicrob Agents Chemother (1986) 1.01
A herpesvirus encoded deubiquitinase is a novel neuroinvasive determinant. PLoS Pathog (2009) 0.99
Genomic sequence of Spodoptera frugiperda Ascovirus 1a, an enveloped, double-stranded DNA insect virus that manipulates apoptosis for viral reproduction. J Virol (2006) 0.99
Colonization of murine ganglia by a superinfecting strain of herpes simplex virus. Infect Immun (1983) 0.97
Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping. Nucleic Acids Res (1989) 0.97
Properties of a novel thymidine kinase induced by an acyclovir-resistant herpes simplex virus type 1 mutant. J Virol (1982) 0.97
Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs. J Virol (1985) 0.96
Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants. Infect Immun (1981) 0.91
Identification of the thymidine kinase gene of feline herpesvirus: use of degenerate oligonucleotides in the polymerase chain reaction to isolate herpesvirus gene homologs. J Virol (1989) 0.90
Systematic annotation and analysis of "virmugens"-virulence factors whose mutants can be used as live attenuated vaccines. Vaccine (2012) 0.88
Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone. Immunology (1984) 0.88
The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections. J Neurovirol (2011) 0.87
Phosphorylation of a herpes simplex virus 1 dUTPase by a viral protein kinase, Us3, dictates viral pathogenicity in the central nervous system but not at the periphery. J Virol (2013) 0.86
Persistence of infectious herpes simplex virus type 2 in the nervous system in mice after antiviral chemotherapy. Antimicrob Agents Chemother (2000) 0.84
Characterization of a varicella-zoster virus variant with altered thymidine kinase activity. Antimicrob Agents Chemother (1986) 0.84
Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection. J Virol (2006) 0.82
Characterization of virulent and attenuated strains of pseudorabies virus for thymidine kinase activity, virulence and restriction patterns. Can J Vet Res (1987) 0.81
Oncolytic viruses. Invest New Drugs (1999) 0.81
Herpes simplex virus-based vectors. Int J Exp Pathol (2004) 0.80
Designing Herpes Viruses as Oncolytics. Mol Ther Oncolytics (2015) 0.79
Roles of conserved residues within the pre-NH2-terminal domain of herpes simplex virus 1 DNA polymerase in replication and latency in mice. J Gen Virol (2014) 0.78
Vaccination of mice and swine with a pseudorabies virus mutant lacking thymidine kinase activity. Can J Vet Res (1987) 0.77
Drug combinations for treatment of mice infected with acyclovir-resistant herpes simplex virus. Antimicrob Agents Chemother (1987) 0.76
Pathologic studies and comparison of the virulence of herpes simplex virus type 2 from Okinawa, Japan and Chiang Mai, Thailand. Int J Exp Pathol (1995) 0.75
Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence. Virol J (2017) 0.75
Hepatic infection by thymidine kinase-positive and thymidine kinase-negative herpes simplex virus after partial hepatectomy. Infect Immun (1983) 0.75
Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses. Front Oncol (2017) 0.75
Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp Med (1950) 43.56
MUTANT STRAINS OF HERPES SIMPLEX DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY. Virology (1964) 6.69
A virus-specific thymidine kinase in BHK-21 cells infected with herpes simplex virus. Virology (1967) 5.22
Induction of both thymidine and deoxycytidine kinase activity by herpes viruses. J Gen Virol (1974) 4.50
Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. J Gen Virol (1975) 4.39
Virus specific antigens in mammalian cells infected with herpes simplex virus. Immunology (1966) 2.59
Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection. Infect Immun (1975) 2.44
Deoxypyrimidine kinases of herpes simplex viruses types 1 and 2: comparison of serological and structural properties. J Gen Virol (1975) 2.04
Latent infection of the peripheral ANS with herpes simplex virus. Nature (1975) 1.76
Serological properties of thymidine kinase produced in cells infected with type 1 or type 2 herpes virus. J Gen Virol (1972) 1.67
The pathogenesis of pseudorabies in mice following peripheral inoculation. J Gen Virol (1974) 1.64
Temperature-sensitive mutants of herpes simplex virus differ in the capacity to establish latent infections in mice. Virology (1977) 1.54
Interaction of herpes virus and HeLa cells: comparison of cell killing and infective center formation. Virology (1962) 1.53
In vivo behaviour of a temperature-sensitive (ts) mutant of herpesvirus hominis type 2. Arch Gesamte Virusforsch (1973) 1.43
Low virulence and immunogenicity in mice and in rabbits of variants of Herpes simplex virus resistant to 5-iodo-2-deoxyuridine. Experientia (1975) 1.10
Resistance to intracerebral challenge in mice immunized against herpes simplex virus. Br J Exp Pathol (1972) 1.08
Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. J Gen Virol (1975) 4.39
Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans. J Virol (1986) 3.36
Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice. Antimicrob Agents Chemother (1979) 2.75
Immunological evidence for a specific DNA polymerase produced after infection by herpes simplex virus. Virology (1966) 2.62
Virus specific antigens in mammalian cells infected with herpes simplex virus. Immunology (1966) 2.59
Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrob Agents Chemother (1980) 2.17
Deoxypyrimidine kinases of herpes simplex viruses types 1 and 2: comparison of serological and structural properties. J Gen Virol (1975) 2.04
Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature (1981) 2.03
Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus. J Gen Virol (1980) 2.01
Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. J Gen Virol (1980) 1.96
Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity. J Gen Virol (1982) 1.70
Introduction of the herpes simplex virus thymidine kinase gene into mouse cells using virus DNA or transformed cell DNA. Cell (1978) 1.69
Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response. J Immunol (1981) 1.66
The pathogenesis of pseudorabies in mice following peripheral inoculation. J Gen Virol (1974) 1.64
Association between psychopathic disorder and serum antibody to herpes simplex virus (type 1). Br Med J (1971) 1.56
Cell-mediated immunity in herpes simplex virus-infected mice: functional analysis of lymph node cells during periods of acute and latent infection, with reference to cytotoxic and memory cells. J Gen Virol (1980) 1.45
Cell-mediated immunity in calves experimentally infected with BHV-1. Vet Rec (1990) 1.39
Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity. Immunology (1981) 1.36
The preparation of 'monoprecipitin' antisera to herpes virus specific antigens. J Gen Virol (1969) 1.32
The progression of herpes simplex virus to the central nervous system of the mouse. J Hyg (Lond) (1967) 1.30
Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy. Antimicrob Agents Chemother (1982) 1.29
Herpes simplex viruses: discrimination of types and correlation between different characteristics. Virology (1974) 1.28
Intra-axonal location of herpes simplex virus particles. J Gen Virol (1972) 1.24
The distribution of herpes simplex type 1 antigen in mouse central nervous system after different routes of inoculation. J Neurol Sci (1983) 1.22
Critical determinants of antiherpes efficacy of buciclovir and related acyclic guanosine analogs. Antiviral Res (1987) 1.21
Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins. J Gen Virol (1976) 1.20
The pathogenesis of pseudorabies in mice: virus replication at the inoculation site and axonal uptake. J Gen Virol (1975) 1.19
Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice. J Gen Virol (1981) 1.18
Pathogenesis of mouse scrapie: evidence for spread of infection from central to peripheral nervous system. J Gen Virol (1983) 1.17
Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. J Virol (1986) 1.17
Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency. J Infect Dis (1996) 1.11
The interaction of herpes simplex virus with cultures of peripheral nervous tissue: an electron microscopic study. J Gen Virol (1973) 1.08
The raising of equine colostrum-deprived foals; maintenance and assessment of specific pathogen (EHV-1/4) free status. Equine Vet J (1991) 1.07
Herpesvirus. Intervirology (1986) 1.07
Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity. Immunology (1981) 1.04
Atypical patterns of neural infection produced in mice by drug-resistant strains of herpes simplex virus. J Gen Virol (1982) 1.02
Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell-mediated and humoral immunity. J Gen Virol (1982) 1.02
Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model. Antimicrob Agents Chemother (1996) 1.02
A quantitative study of the effects of several nucleoside analogues on established herpes encephalitis in mice. J Gen Virol (1984) 0.98
Serological relationships among viruses of the herpes group. J Gen Virol (1967) 0.98
CYTOCHEMICAL STUDIES OF THE NUCLEOPROTEINS OF HELA CELLS INFECTED WITH HERPES VIRUS. J Cell Biol (1963) 0.97
The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J Gen Virol (1990) 0.97
Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir. Antiviral Res (1984) 0.97
Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir. Antiviral Res (1982) 0.96
The synthesis of polyadenylated messenger RNA in herpes simplex type I virus infected BHK cells. J Gen Virol (1975) 0.96
The host response to herpes simplex virus. Br Med Bull (1985) 0.96
What's in a virus name? Nature (1966) 0.96
Inhibition of herpes simplex virus multiplication by activated macrophages: a role for arginase? Infect Immun (1982) 0.95
A perspective on resistance to acyclovir in herpes simplex virus. J Antimicrob Chemother (1983) 0.95
Combinations of antiviral and anti-inflammatory preparations for the topical treatment of herpes simplex virus assessed using a murine zosteriform infection model. Antivir Chem Chemother (1998) 0.94
Antiviral drug resistance. Trends Pharmacol Sci (1989) 0.94
A serological study of canine herpes virus-1 infection in the English dog population. Arch Virol (1998) 0.93
Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Arch Virol (1992) 0.93
Sensitivity of viruses to phosphorylated 9-(2-hydroxyethoxymethyl)guanine revealed in TK-transformed cells. J Gen Virol (1980) 0.92
The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. J Gen Virol (1994) 0.92
The use of monoclonal antibodies in (reverse) passive haemagglutination tests for herpes simplex virus antigens and antibodies. J Med Virol (1983) 0.92
Analysis of the bovine herpesvirus type 1 thymidine kinase (TK) gene from wild-type virus and TK-deficient mutants. J Gen Virol (1989) 0.92
Experimental reactivation of bovine herpesvirus 1 (BHV-1) by means of corticosteroids in an intranasal rabbit model. Arch Virol (1990) 0.90
Formation of small plaques by herpes viruses irradiated with ultraviolet light. Virology (1971) 0.90
Role of neutralizing antibodies and T-cells in pathogenesis of herpes simplex virus infection in congenitally athymic mice. Immunol Lett (1982) 0.89
Recurrent herpes simplex: the outlook for systemic antiviral agents. Br Med J (Clin Res Ed) (1981) 0.89
Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study. Antimicrob Agents Chemother (1998) 0.89
The development of retinitis in mice with nonfatal herpes simplex encephalitis. Neuropathol Appl Neurobiol (1982) 0.89
Definition of a virulence-related antigen of Neisseria gonorrhoeae with monoclonal antibodies and lectins. J Infect Dis (1986) 0.88
Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J Gen Virol (1994) 0.88
Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone. Immunology (1984) 0.88
Latency and acquired resistance--problems in chemotherapy of herpes infections. Pharmacol Ther (1983) 0.88
The detection of latency-associated transcripts of equine herpesvirus 1 in ganglionic neurons. J Gen Virol (1995) 0.87
The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment. J Gen Virol (2000) 0.87
Ganciclovir and penciclovir, but not acyclovir, induce apoptosis in herpes simplex virus thymidine kinase-transformed baby hamster kidney cells. Antivir Chem Chemother (2001) 0.87
Development and localization of virus-specific antigens during the multiplication of herpes simplex virus in BHK 21 cells. J Gen Virol (1968) 0.87
Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin. J Med Microbiol (1975) 0.86
An historical account of the development and applications of the negative staining technique to the electron microscopy of viruses. J Microsc (1979) 0.86
Persistence of infectious herpes simplex virus type 2 in the nervous system in mice after antiviral chemotherapy. Antimicrob Agents Chemother (2000) 0.84
An animal model of ocular herpes. Keratitis, retinitis and cataract in the mouse. Br J Exp Pathol (1984) 0.84
The pathogenicity of Ab4p, the sequenced strain of equine herpesvirus-1, in specific pathogen-free foals. Virology (1992) 0.84
Genomic localization and sequence analysis of the putative bovine herpesvirus-1 DNA polymerase gene. Arch Virol (1988) 0.84
Serological responses of specific pathogen-free foals to equine herpesvirus-1: primary and secondary infection, and reactivation. Vet Microbiol (1992) 0.83
Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus. J Gen Virol (1988) 0.82
Herpes simplex virus zosteriform lesions with adoptive transfer of immune cells: a murine model which mimics human recurrent disease. Antiviral Res (1998) 0.82
Virological and molecular biological investigations into equine herpes virus type 2 (EHV-2) experimental infections. Virus Res (1998) 0.82
Ultraviolet irradiation of herpes simplex virus: reactivation processes and delay in virus multiplication. J Gen Virol (1972) 0.82
Modulation of the serological response of specific pathogen-free (EHV-free) foals to EHV-1 by previous infection with EHV-4 or a TK-deletion mutant of EHV-1. Arch Virol (1993) 0.81
Herpes simplex virus latency and nucleoside analogues. Antiviral Res (1999) 0.81
Ultraviolet irradiation of herpes simplex virus (type 1): delayed transcription and comparative sensitivites of virus functions. J Gen Virol (1980) 0.81
Antigens of herpes simplex virus of oral and genital origin. Cancer Res (1973) 0.81
The activity of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine (HPMPC) against equine herpesvirus-1 (EHV-1) in cell cultures, mice and horses. Antiviral Res (1992) 0.81
Isolation and characterization of acyclovir-resistant strains of herpes simplex virus. Am J Med (1982) 0.80
A murine model for studying EHV-1-induced abortion. Res Vet Sci (1991) 0.80
Can HSV latency be conquered by current antiviral therapies? Sex Transm Infect (1998) 0.80
Molecular studies of the acute infection, latency and reactivation of equine herpesvirus-1 (EHV-1) in the mouse model. Virus Res (1996) 0.80
The effect of (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine (HPMPC) on bovine herpesvirus-1 (BHV-1) infection and reactivation in cattle. Antiviral Res (1993) 0.80